Abstract Background: Natural Procreative Technology (NaProTechnology) is a system of management of infertility and other reproductive health issues which requires the application of the observations made by a woman and record of key events throughout her menstrual cycle. Objectives: The study assessed the knowledge, awareness, and perception of NaProTechnology as well as the effect of an educational intervention among pharmacy undergraduate students at University of Nigeria, Nsukka. Methods: It was a cross-sectional, questionnaire-based study. The ethical approval was obtained from the research ethics committee of the Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka. At baseline, the knowledge, awareness and perception of the students were assessed. Followed by the administration of an educational video on NaProTechnology. Then a post intervention survey was done to assess the effect of the educational intervention. Key findings: There were 410 and 350 students in the pre- and post-intervention surveys respectively with relatively equal number of males and females. Majority were between 18 and 29 years old. Those in third year of study had the best knowledge (P=0.002) and awareness (P=0.021) and most positive perception (P=0.035) of NaProTechnology. The knowledge, awareness, and positive perception of NaProTechnology among the pharmacy students prior to intervention were poor but improved markedly post intervention (P < 0.001). Conclusion: A video intervention was effective in improving the short-term knowledge, awareness and positive perception of NaProTechnology among pharmacy students. We recommend the public health system approach of informing, educating and communicating NaProTechnology to pharmacists to achieve long-term effects. Well-designed courses as well as including NaProTechnology in the curriculum are specific ways that can be used to achieve this among pharmacy students. Keywords: NaProTechnology; educational-intervention; pharmacy-students; curriculum

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethical clearance was sought and received from the Ethics Research Committee of the Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka on 15th July, 2020 (FPSRE/UNN/20/0007).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors